Alibaba crackdown has implications for emerging market equities Alibaba crackdown has implications for emerging market equities Alibaba crackdown has implications for emerging market equities

Alibaba crackdown has implications for emerging market equities

Equities 4 minutes to read
Peter Garnry

Head of Equity Strategy

Summary:  China has increasingly changed regulation regarding antitrust and recently the government said that large technology companies were a threat to the Chinese consumer and competition. Last Thursday, the Chinese antitrust regulators launched an official antitrust investigation of Alibaba causing its shares to decline 8%. Today, Chinese regulators are demanding Ant (Alibaba's financial arm) to return to its 'roots' in payments 'as soon as possible' exiting its businesses in consumer loans, wealth management, and insurance. This has caused sentiment to sour across all Chinese technology stocks and with the sector being a big part of the leading index on emerging market equities this could have big implications for our positive on EM equities in 2021.

Alibaba shares are down 8% in Hong Kong today extending the decline from last Thursday when the Chinese government officially launched its antitrust investigation against Alibaba. The decline today is driven by Chinese regulators ordering Ant (Alibaba’s financial arm) to ‘as soon as possible’ to exit its businesses in consumer loans, wealth management, and insurance, and go back to its ‘roots’ in payments.

Alibaba shares on the Hong Kong Stock Exchange since inception

Source: Saxo Group

This will severely restrict growth at Ant and lower its valuation which was deemed as high as $300bn in the recently postponed IPO due to changing regulation of ‘fintech’ companies not currently under the same oversight as traditional banks in China. While last Thursday’s announcement of an official antitrust investigation of Alibaba had limited impact on Tencent, Baidu and, the market is changing its views of the wider Chinese technology sector in today’s trading.

While the Alibaba crackdown is a paradigm shift in China and will likely cause headwinds for Chinese technology stocks, we are cautious about extrapolating the events in China to the rising antitrust cases in the US and Europe against big US technology companies. Due to the differences in the political systems the playbook will not be the same and we do not think Western governments will be as aggressive. Therefore, the immediate implication is not that of US technology stocks, but emerging market equities overall as Alibaba, Tencent, Meituan, Naspers, and are 14% of the overall MSCI Emerging Markets Index (see overview of ETF holdings below). This is obviously a threat to our positive view on emerging market equities, which we have expressed in several analyses including this one from 23 November, because the Chinese technology sector is a key driver to emerging market outperformance in 2021.

iShares Core MSCI EM IMI UCITS ETF and 10 largest holdings

Source: Saxo Group
Source: Bloomberg

Saxo Capital Markets (Australia) Limited prepares and distributes information/research produced within the Saxo Bank Group for informational purposes only. In addition to the disclaimer below, if any general advice is provided, such advice does not take into account your individual objectives, financial situation or needs. You should consider the appropriateness of trading any financial instrument as trading can result in losses that exceed your initial investment. Please refer to our Analysis Disclaimer, and our Financial Services Guide and Product Disclosure Statement. All legal documentation and disclaimers can be found at

The Saxo Bank Group entities each provide execution-only service. Access and use of Saxo News & Research and any Saxo Bank Group website are subject to (i) the Terms of Use; (ii) the full Disclaimer; and (iii) the Risk Warning in addition (where relevant) to the terms governing the use of the website of a member of the Saxo Bank Group.

Saxo News & Research is provided for informational purposes, does not contain (and should not be construed as containing) financial, investment, tax or trading advice or advice of any sort offered, recommended or endorsed by Saxo Bank Group and should not be construed as a record of our trading prices, or as an offer, incentive or solicitation for the subscription, sale or purchase in any financial instrument. No representation or warranty is given as to the accuracy or completeness of this information. All trading or investments you make must be pursuant to your own unprompted and informed self-directed decision. No Saxo Bank Group entity shall be liable for any losses that you may sustain as a result of any investment decision made in reliance on information on Saxo News & Research.

To the extent that any content is construed as investment research, such content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, would be considered as a marketing communication.

None of the information contained here constitutes an offer to purchase or sell a financial instrument, or to make any investments.Saxo Capital Markets does not take into account your personal investment objectives or financial situation and makes no representation and assumes no liability as to the accuracy or completeness of the information nor for any loss arising from any investment made in reliance of this presentation. Any opinions made are subject to change and may be personal to the author. These may not necessarily reflect the opinion of Saxo Capital Markets or its affiliates.

Please read our disclaimers:
- Full Disclaimer (
- Analysis Disclaimer (
- Notification on Non-Independent Investment Research (

Saxo Capital Markets (Australia) Limited
Suite 1, Level 14, 9 Castlereagh St
Sydney NSW 2000

Contact Saxo

Select region


The Saxo trading platform has received numerous awards and recognition. For details of these awards and information on awards visit

Saxo Capital Markets (Australia) Limited ABN 32 110 128 286 AFSL 280372 (‘Saxo’ or ‘Saxo Capital Markets’) is a wholly owned subsidiary of Saxo Bank A/S, headquartered in Denmark. Please refer to our General Business Terms, Financial Services Guide, Product Disclosure Statement and Target Market Determination to consider whether acquiring or continuing to hold financial products is suitable for you, prior to opening an account and investing in a financial product.

Trading in financial instruments carries various risks, and is not suitable for all investors. Please seek expert advice, and always ensure that you fully understand these risks before trading. Saxo Capital Markets does not provide ‘personal’ financial product advice, any information available on this website is ‘general’ in nature and for informational purposes only. Saxo Capital Markets does not take into account an individual’s needs, objectives or financial situation. The Target Market Determination should assist you in determining whether any of the products or services we offer are likely to be consistent with your objectives, financial situation and needs.

Apple, iPad and iPhone are trademarks of Apple Inc., registered in the US and other countries. AppStore is a service mark of Apple Inc.

The information or the products and services referred to on this website may be accessed worldwide, however is only intended for distribution to and use by recipients located in countries where such use does not constitute a violation of applicable legislation or regulations. Products and Services offered on this website is not intended for residents of the United States and Japan.

Please click here to view our full disclaimer.